# Adversarial Review Round 1
# Date: 2026-08-28T16:10:00Z
# Focus: Accuracy and Engagement

## Personas Applied
- Accuracy Checker
- Bored Reviewer
- Skeptical Expert

---

## ACCURACY CHECKER FINDINGS

### Numerical Verification

| Paper Claim | Ground Truth | Status |
|-------------|--------------|--------|
| Quadratic R²=0.985 | 0.985 | ✓ MATCH |
| Linear R²=0.45 | 0.45 | ✓ MATCH |
| AIC difference=58 | 58 | ✓ MATCH |
| Peak at p44.5 | p44.5 | ✓ MATCH |
| 95% CI [p40, p50] | [p40, p50] | ✓ MATCH |
| p0 AUC 6.33e8 | 6.33e8 | ✓ MATCH |
| p50 AUC 4.55e8 | 4.55e8 | ✓ MATCH |
| 40% noise dilution ratio | 1.40 | ✓ MATCH |
| RedPajama defaults 0.783 | 0.783 | ✓ MATCH |
| CPDR-optimized 0.793 | 0.793 | ✓ MATCH |
| Improvement 1.32% | 1.32% | ✓ MATCH |
| Transfer ratio 0.85 | 0.85 | ✓ MATCH |

**Verdict:** All numerical claims verified against ground truth (065_ground_truth.yaml). No discrepancies found.

---

## BORED REVIEWER FINDINGS

### Persuasiveness Checks

| Check | Result | Notes |
|-------|--------|-------|
| Abstract compelling? | YES | Concrete problem + specific results |
| Problem clear in 1 minute? | YES | Section 1.1 clear framing |
| Novelty clear in 2 minutes? | YES | "First controlled dose-response study" explicit |
| Figure 1 self-explanatory? | N/A | Figures referenced but not embedded in markdown |
| Would continue reading? | YES | Strong hook maintained |
| Attention lost at? | NEVER | Focus maintained throughout |

**Verdict:** Paper is engaging. No attention loss points.

---

## SKEPTICAL EXPERT FINDINGS

### Novelty Claims Assessment

1. **"First controlled dose-response study"** - VALID. Related work correctly identifies gap.
2. **"Transforms curation from art to science"** - Acceptable rhetorical claim with evidence.

### Baseline Fairness

- RedPajama defaults as baseline: FAIR (industry standard)
- Same token budget, architecture: FAIR methodology

### Overclaims Check

1. **R1-001 [MAJOR]**: Mock evaluation caveat insufficiently prominent
   - Paper claims "1.32% improvement" in Abstract/Results
   - Ground truth notes "Mock evaluation at 1/2000 scale"
   - Caveat appears only in Discussion Section 6.2
   - **Risk:** Readers may misunderstand magnitude as production-ready

### Limitations Coverage

| Limitation | Disclosed? | Location |
|------------|------------|----------|
| Mock/synthetic evaluation | YES | Section 6.2 |
| Single architecture (GPT-2) | YES | Section 6.2 |
| Single dataset (RedPajama) | YES | Section 6.2 |
| H-M2 inconclusive | YES | Section 6.2 |
| Single-parameter sweeps | YES | Section 6.2 |

**Verdict:** Limitations honestly disclosed but caveat placement needs improvement.

---

## ISSUES SUMMARY

| ID | Severity | Category | Description | Fix Required |
|----|----------|----------|-------------|--------------|
| R1-001 | MAJOR | overclaim_risk | Mock evaluation caveat (PoC scale) mentioned only in Discussion; should appear in Abstract and Results summary table | YES |

### FATAL Issues: 0
### MAJOR Issues: 1
### Human Review Notes: 0

---

## REVISION ACTIONS TAKEN

### R1-001 Fix Applied

**Abstract (00_abstract.md):**
- Changed: "demonstrate 1.32% improvement over industry-standard defaults"
- To: "demonstrate 1.32% improvement over industry-standard defaults at proof-of-concept scale"

**Results Section 5.6 (06_paper.md):**
- Added note after Summary of Evidence table:
  > **Note:** All results obtained at proof-of-concept scale (5M-10M tokens, mock evaluation). Effect magnitudes are directional; full-scale replication required for production deployment.

---

## R1 CONVERGENCE STATUS

- FATAL issues: 0
- MAJOR issues: 1 → 0 (fixed)
- Persuasiveness: PASSED
- Proceed to: R2 (numerical verification with Serena MCP)
